Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

William M. Crist, James R. Anderson, Jane L. Meza et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005

Simona Ognjanovic, Amy M. Linabery, Bridget Charbonneau et al. · Cancer · 2009 · 475 citations · Full text

Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.

Hajime Hosoi, Michael B. Dilling, Takuma Shikata et al. · PubMed · 1999 · 316 citations

Apoptosis, Cell Death, Cell Proliferation +23

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS‐I Through IRS‐IV Studies as Background for the Current IRS‐V Treatment Protocols

R. Beverly Raney, Harold M. Maurer, James R. Anderson et al. · Sarcoma · 2001 · 303 citations · Full text

Embryonal Rms, Surgical Oncology, Pathology +16

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis

Elai Davicioni, Michael J. Anderson, Friedrich Graf Finckenstein et al. · American Journal Of Pathology · 2009 · 291 citations · Full text